Lynch TJ - Search Results

1

Polymorphisms in the DNA repair genes XRCC1 and ERCC2, smoking, and lung cancer risk.

Zhou W, Liu G, Miller DP, Thurston SW, Xu LL, Wain JC, Lynch TJ, Su L, Christiani DC. Zhou W, et al. Among authors: lynch tj. Cancer Epidemiol Biomarkers Prev. 2003 Apr;12(4):359-65. Cancer Epidemiol Biomarkers Prev. 2003. PMID: 12692111

2

Counterpoint: the myeloperoxidase -463G-->a polymorphism does not decrease lung cancer susceptibility in Caucasians.

Xu LL, Liu G, Miller DP, Zhou W, Lynch TJ, Wain JC, Su L, Christiani DC. Xu LL, et al. Among authors: lynch tj. Cancer Epidemiol Biomarkers Prev. 2002 Dec;11(12):1555-9. Cancer Epidemiol Biomarkers Prev. 2002. PMID: 12496043

3

No association between the p21 codon 31 serine-arginine polymorphism and lung cancer risk.

Su L, Liu G, Zhou W, Xu LL, Miller DP, Park S, Lynch TJ, Wain JC, Christiani DC. Su L, et al. Among authors: lynch tj. Cancer Epidemiol Biomarkers Prev. 2003 Feb;12(2):174-5. Cancer Epidemiol Biomarkers Prev. 2003. PMID: 12582031 Clinical Trial. No abstract available.

4

Association between self-reported environmental tobacco smoke exposure and lung cancer: modification by GSTP1 polymorphism.

Miller DP, De Vivo I, Neuberg D, Wain JC, Lynch TJ, Su L, Christiani DC. Miller DP, et al. Among authors: lynch tj. Int J Cancer. 2003 May 10;104(6):758-63. doi: 10.1002/ijc.10989. Int J Cancer. 2003. PMID: 12640684

5

P53 (codon 72) and P21 (codon 31) polymorphisms alter in vivo mRNA expression of p21.

Su L, Sai Y, Fan R, Thurston SW, Miller DP, Zhou W, Wain JC, Lynch TJ, Liu G, Christiani DC. Su L, et al. Among authors: lynch tj. Lung Cancer. 2003 Jun;40(3):259-66. doi: 10.1016/s0169-5002(03)00081-3. Lung Cancer. 2003. PMID: 12781424

6

Smoking and the risk of lung cancer: susceptibility with GSTP1 polymorphisms.

Miller DP, Neuberg D, de Vivo I, Wain JC, Lynch TJ, Su L, Christiani DC. Miller DP, et al. Among authors: lynch tj. Epidemiology. 2003 Sep;14(5):545-51. doi: 10.1097/01.ede.0000073120.46981.24. Epidemiology. 2003. PMID: 14501269

7

XPD and XRCC1 genetic polymorphisms are prognostic factors in advanced non-small-cell lung cancer patients treated with platinum chemotherapy.

Gurubhagavatula S, Liu G, Park S, Zhou W, Su L, Wain JC, Lynch TJ, Neuberg DS, Christiani DC. Gurubhagavatula S, et al. Among authors: lynch tj. J Clin Oncol. 2004 Jul 1;22(13):2594-601. doi: 10.1200/JCO.2004.08.067. Epub 2004 Jun 1. J Clin Oncol. 2004. PMID: 15173214 Clinical Trial.

8

Excision repair cross-complementation group 1 polymorphism predicts overall survival in advanced non-small cell lung cancer patients treated with platinum-based chemotherapy.

Zhou W, Gurubhagavatula S, Liu G, Park S, Neuberg DS, Wain JC, Lynch TJ, Su L, Christiani DC. Zhou W, et al. Among authors: lynch tj. Clin Cancer Res. 2004 Aug 1;10(15):4939-43. doi: 10.1158/1078-0432.CCR-04-0247. Clin Cancer Res. 2004. PMID: 15297394

9

MPO and SOD2 polymorphisms, gender, and the risk of non-small cell lung carcinoma.

Liu G, Zhou W, Wang LI, Park S, Miller DP, Xu LL, Wain JC, Lynch TJ, Su L, Christiani DC. Liu G, et al. Among authors: lynch tj. Cancer Lett. 2004 Oct 8;214(1):69-79. doi: 10.1016/j.canlet.2004.06.027. Cancer Lett. 2004. PMID: 15331175

10

The SOD2 Val/Val genotype enhances the risk of nonsmall cell lung carcinoma by p53 and XRCC1 polymorphisms.

Liu G, Zhou W, Park S, Wang LI, Miller DP, Wain JC, Lynch TJ, Su L, Christiani DC. Liu G, et al. Among authors: lynch tj. Cancer. 2004 Dec 15;101(12):2802-8. doi: 10.1002/cncr.20716. Cancer. 2004. PMID: 15534883 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

355 results

Search Page

Filters